Melanoma: A model for testing new agents in combination therapies

Por Ascierto, Paolo A, Streicher, Howard Z, Sznol, Mario
Publicado em 2010

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

Por Dobbin, Kevin K., Cesano, Alessandra, Alvarez, John, Hawtin, Rachael, Janetzki, Sylvia, Kirsch, Ilan, Masucci, Giuseppe V., Robbins, Paul B., Selvan, Senthamil R., Streicher, Howard Z., Zhang, Jenny, Butterfield, Lisa H., Thurin, Magdalena
Publicado no J Immunother Cancer (2016)

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

Por Masucci, Giuseppe V., Cesano, Alessandra, Hawtin, Rachael, Janetzki, Sylvia, Zhang, Jenny, Kirsch, Ilan, Dobbin, Kevin K., Alvarez, John, Robbins, Paul B., Selvan, Senthamil R., Streicher, Howard Z., Butterfield, Lisa H., Thurin, Magdalena
Publicado no J Immunother Cancer (2016)

Biology of Advanced Uveal Melanoma and Next Steps for Clinical Therapeutics

Por Luke, Jason J., Triozzi, Pierre L., McKenna, Kyle C., Van Meir, Erwin G., Gershenwald, Jeffrey E., Bastian, Boris C., Gutkind, J. Silvio, Bowcock, Anne M., Streicher, Howard Z., Patel, Poulam M., Sato, Takami, Sossman, Jeffery A., Sznol, Mario, Welch, Jack, Thurin, Magdalena, Selig, Sara, Flaherty, Keith T., Carvajal, Richard D.
Publicado no Pigment Cell Melanoma Res (2014)